BRKR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Bruker Corp (BRKR) is not a strong buy for a beginner, long-term investor at this time. The stock's underperformance, lack of positive momentum, and mixed financial and analyst sentiment suggest that it is better to wait for clearer signs of recovery or stability before investing.
The MACD is positive but contracting, RSI is neutral at 62.855, and moving averages are converging, indicating no strong trend. The stock is trading near its support levels (S1: 35.6) but has not shown a clear breakout above resistance levels (R1: 40.191).
Introduction of new NMR products and workflow solutions to enhance research efficiency and data accuracy. Recent 4% stock price increase following product announcement.
Rising helium prices could pose a headwind due to the company's exposure.
In Q4 2025, revenue slightly declined by -0.24% YoY, while net income increased by 8.76% YoY. EPS rose by 11.11% YoY, but gross margin dropped by -6.05% YoY, reflecting mixed performance.
Analyst sentiment is mixed. Barclays and Guggenheim maintain Buy/Overweight ratings but have lowered price targets. Goldman Sachs has a Sell rating with a $35 price target. The consensus reflects cautious optimism with concerns over execution risks and sector-specific challenges.
